Tusker Medical said yesterday that it raised more than $10 million for the pediatric ear surgery device it’s developing. The Menlo Park, Calif.-based company raised $10.2 million in an equity sale from a single unnamed investor, according to a regulatory filing. Tusker, formerly known as Advanced ENT Solutions, is developing a new technique for tympanostomies, in […]
Ear Nose & Throat (ENT)
Intersect ENT claims reimbursement win for Propel drug-eluting sinus implant
Intersect ENT (NSDQ:XENT) said today that it won a positive coverage decision from CareFirst BlueCross BlueShield for its Propel and Propel Mini drug-eluting sinus implants. The devices are designed to elute the anti-inflammatory steroid mometasone furoate; Menlo Park, Calif.-based Intersect won FDA approval for the original Propel implant in August 2011 and for the Propel Mini the following September. The […]
